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LP-BM5 murine leukemia virus-infected C57BL/6 mice develop profound immunodeficiency and B-cell
lymphomas. The LP-BM5 complex contains a mixture of defective (BM5def) and replication-competent helper
viruses among which BM5def is the primary causative agent of disease. The BM5def primary open reading
frame (ORF1) encodes the single gag precursor protein (Pr60gag). Our lab has recently demonstrated that a
novel immunodominant cytotoxic-T-lymphocyte (CTL) epitope (SYNTGRFPPL) is expressed from a 1-
nucleotide translational open reading frame of BM5def during the course of normal retrovirus expression. The
SYNTGRFPPL CTL epitope may be generated from either of two initiation methionines present, ORF2a or
ORF2b, located downstream of the ORF1 initiation site. This study investigates the role(s) of the alternative
ORF2-derived gag protein(s) of BM5def in viral pathogenesis. We have examined the disease-inducing capa-
bilities of mutant viruses in which the translational potential of either the initiating ORF2a or ORF2b AUG
has been disrupted. Although these mutated viruses are capable of wild-type ORF1 expression, they are unable
to induce disease. Our data strongly suggest the existence of a novel ORF2 product(s) that is required for
LP-BM5-induced pathogenesis and have potentially broad implications for other retroviral diseases.
Genetically susceptible C57BL/6 (B6) mice infected with the
LP-BM5 retroviral isolate (18) develop immunodeficiency sim-
ilar to AIDS. This disease is called murine AIDS (MAIDS),
stages of which are characterized by splenomegaly, lymphade-
nopathy, hypergammaglobulinemia, profound immunodefi-
ciency, and B-cell lymphomas in the context of retroviral-in-
duced immunodeficiency, generally similar to AIDS-related
non-Hodgkin’s lymphomas. Among the three classes of murine
leukemia viruses (MuLV) in the LP-BM5 isolate, the BM5eco
(and possibly recombinant mink cell focus-forming virus)
MuLV function as helper viruses for the replication-defective
BM5def, which is the primary etiological agent causing disease
(1, 4, 13, 18). Two molecular clones of the defective genome,
Du5H and DEF27, have been characterized from different
isolates, with both revealing large common regions of pol and
env that have been deleted (1, 5). The BM5def primary open
reading frame (ORF1) encodes the single gag precursor pro-
tein (Pr60gag). The BM5def gag sequences encoding the core
proteins MA (p15), CA (p30), and NC (p10) have 80 to 90%
homology to the analogous sequences in the Pr65gag of other
ecotropic MuLV. However, within a 25-amino acid (aa) seg-
ment at the carboxy-terminal end of p15 and another 25-aa
region in p12, BM5def displays a distinctively high diversity
from the nonpathogenic BM5eco and other typical replication-
competent ecotropic MuLV (1, 5) (Fig. 1A).
All of the work done to understand LP-BM5-induced patho-
genesis, including yeast two-hybrid screening for host proteins
that bind BM5def gag protein, has focused conceptually on the
BM5def ORF1-encoded Pr60gag protein exclusively. The es-
sential role of ORF1 in pathogenesis has been established by
generating a myristylation-negative (Myr) Pr60gag mutant of
BM5def (Du5H clone) (12). Similar to other myristylated pro-
teins, Pr60gag on myristylation attaches to the inner leaflet of
the plasma membrane. Following this, myristylated Pr60gag
may interact with other membrane-bound molecules leading to
disease. The Myr Pr60gag mutant BM5def is unable to induce
either the expansion of target B cells or the splenomegaly
characteristic of MAIDS, demonstrating that an unaltered
Pr60gag ORF1 is necessary for viral pathogenesis (12). Other
groups have also established the crucial roles of ORF1 coding
regions of the Pr60gag gene in pathogenesis. By examining the
disease-inducing potential of MuLV-rescued BM5def carrying
truncated gag, it has been proposed that the MA (p15)- and
p12-encoding regions of BM5def gag are sufficient for patho-
genicity (24). Also, substitution of the p15 and p12 sequences
of BM5def virus with BM5eco-specific sequences eliminates its
ability to induce MAIDS (17). Furthermore, by comparing
chimeric viruses with mutated p12 regions, the unique nucle-
otide sequence in the BM5def p12gag region, not homologous
to BM5eco, appears crucial for MAIDS development (16, 17).
Collectively, these observations (12, 16, 17, 24) have been
taken as confirmation of the essential role of ORF1 in patho-
genesis.
However, these studies have concentrated on modifying only
nucleotide sequences and considering their resultant changes
in the ORF1-derived Pr60gag polypeptide. The potential that
alternative open reading frames (and consequently proteins
encoded by them) are embedded within the BM5def gag gene
and may play an important role in pathogenesis of BM5def has
not yet been studied. In addition to studying viral pathogenesis,
our lab has focused on protective immune responses in
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MAIDS-resistant BALB/c mice (20, 22, 26). We and others
have shown that resistance in H-2a and H-2d mouse strains is
primarily dependent on CD8 T cells (19, 20, 22, 23, 26, 27).
Specifically, we have demonstrated that an H-2Kd-restricted
immunodominant cytotoxic-T-lymphocyte (CTL) epitope is
nontraditionally expressed from an alternative translational
gag ORF during the course of normal in vivo and in vitro
LP-BM5 retrovirus expression (22). Thus, we have shown that
in MAIDS-resistant BALB/cByJ, C57BL/KsJ, and (BALB/c 
C57BL/6)F1 mice, CTLs raised against BM5eco or BM5def gag
protein are directed against the conserved p30-encoding re-
gion, but in fact are specific for a novel epitope (SYNTG
RFPPL) generated from a second, 1-nucleotide (nt) register
defined as ORF2 (20, 22). Our lab also demonstrated that, in
the context of the extended minigene constructs used for min-
imal epitope mapping, generation of SYNTGRFPPL depends
on a naturally occurring ORF2 Met initiation codon (22).
Hence, it seems likely that SYNTGRFPPL expression in the
context of full-length BM5def gag is also the result of conven-
tional AUG-directed translation. Thus, the SYNTGRFPPL
epitope may be generated from either one of two potential
initiation codons in BM5def gag ORF2, i.e., starting at 157
(ORF2a AUG) or 646 (ORF2b AUG) nt, respectively, down-
stream of the ORF1 AUG. According to the Kozak consensus
sequence (15), ORF2a is in a strong, and ORF2b is in a very
strong, initiation codon context (21, 22). This extended alter-
FIG. 1. (A) Differences in alternative ORF coding potentials of BM5eco and BM5def. (B) Generation of BM5defORF2aAUGmut and
BM5defORF2bAUGmut viruses.
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native gag ORF is unique for retroviral systems, especially
when comparing BM5def to other ecotropic MuLV such as
AKR623, Friend, and Moloney. Furthermore, given the usual
frequent random occurrences of stop codons in the 1- and
2-nt registers, the extended BM5def ORF2 predicted
maximum protein is unusually long at 193 aa (Fig. 1A).
Based on these observations, the present study examines the
role(s), if any, of the alternative ORF2-derived gag protein(s)
of BM5def in viral pathogenesis. Significantly, as the patho-
genic BM5def viral component is replication incompetent, the
putative ORF2 protein(s) it encodes cannot be crucial to rep-
lication. Rather, we hypothesize that in addition to the primary
ORF1-encoded Pr60gag, BM5def ORF2 translation proceeding
from the ORF2a and/or ORF2b AUG(s) gives rise to pro-
tein(s) of 193 or 30 aa in length (maximally), and one or both
of these ORF2 products are required for LP-BM5 viral patho-
genesis per se.
MATERIALS AND METHODS
Viruses. LP-BM5 was prepared in our laboratory as previously described (11).
The molecular clone for the wild-type (wt) BM5def, p127/A1, generously pro-
vided by Sisir Chattopadhyay, was used to generate the BM5defORF2aAUGmut
or BM5defORF2bAUGmut mutant viruses. A QuickChange kit from Stratagene
was used for site-directed mutagenesis. The primers used to generate the
BM5defORF2aAUGmut mutant were 5 CCACTAGACGGTACTTTTAATTT
AGAC and 3 AATGTCTAAATTAAAAGTACCGTCTAG. To generate the
BM5defORF2bAUGmut mutant, the primers used were 5 GTATTGTAACTGA
CCGTTACCCCCCAAACG and 3 CGTTTGGGGGGTAACGGTCAGTTAC
AATAC.
Mice. Seven-week-old male C57BL/6NCr mice were purchased from the Na-
tional Cancer Institute, housed at the Dartmouth Medical School animal facility,
and infected intraperitoneally with 2.5  104 PFU of LP-BM5 or BM5eco-
rescued wt BM5def or BM5defORF2aAUGmut or BM5defORF2bAUGmut viruses
at 8 to 10 weeks of age.
Activational and immunosuppressive parameters of MAIDS pathogenesis.
Enzyme-linked immunosorbent assay determinations of serum immunoglobulin
(Ig), splenomegaly measurements, allo-CTL and 51Cr release assays, and prolif-
eration assays in response to mitogen were carried out as previously described
(11).
BM5def gag GFP-tagged fusion proteins. We used the enhanced green fluo-
rescent protein (EGFP) to generate the wt or mutant ORF1AUGEGFP or
ORF2AUGEGFP fusion proteins. The GFP fragment was subcloned out of the
pEGFP-N1 plasmid (BD Biosciences, Clontech) and in frame with the AUGs of
the BM5def ORF1, BM5def ORF2a, or BM5def ORF2b.
Viral load. By using a real-time SYBR-Green/iCycler iQ-based quantitative
assay that our lab has recently developed (7), quantitative reverse transcription-
PCR (qRT-PCR) assays were used to quantify BM5def and BM5eco gag RNA
levels. Primers used in this qRT-PCR assay were designed to specifically distin-
guish between BM5def gag and BM5eco gag and have been described previously
(7). It is important to note that primers for BM5eco gag were generated by using
unique BM5eco sequences found at base pairs 1188 and 1370 relative to the
BM5eco gag initiating ATG and these defining nucleotides specific to BM5eco
(and not to BM5def) were positioned at the 3 end.
RESULTS AND DISCUSSION
Presence of alternative reading frames in BM5def and gen-
eration of BM5defORF2aAUGmut and BM5defORF2bAUGmut
mutant viruses. By using site-directed mutagenesis, we intro-
duced a series of nucleotide changes in the BM5def molecular
clone, Def27, to disrupt the translational potential of either the
ORF2a or ORF2b AUG-defined reading frames. These mu-
tants carrying disrupted ORF2a or ORF2b AUGs are referred
to as either BM5defORF2aAUGmut or BM5defORF2bAUGmut
viruses, respectively. The mutations in ORF2a or ORF2b were
carefully designed so as to alter neither the sequence integrity
nor the preferred mammalian codon usage (8) of ORF1. The
BM5defORF2aAUGmut virus was generated by mutating the
most-5 ORF2 start AUG (nt 157 to 159) to ACG and addi-
tionally introducing a stop codon at position 169 to 171 (Fig.
1A and B). The BM5defORF2bAUGmut virus was generated by
mutating the more-3 ORF2 AUG (nt 646 to 648) to ACG, as
it was impossible to engineer an adjacent stop codon without
altering the amino acid coding sequence in ORF1 (Fig. 1B).
Viral stocks were produced by generating stable transfectants
of the wt BM5def (as a transfection control) or the mutated
viruses in SC-1eco cells that are chronically infected with the
helper BM5eco virus. BM5eco-rescued viral stocks, prior to
injection into B6 mice, were confirmed for the presence of
BM5eco and BM5def (wt or mutants) by RT-PCR and real-
time qRT-PCR assays (7) (data not shown). In addition, the
mutations were verified by sequencing. Viral stocks were ad-
justed for delivery of an equivalent infectious titer of 2.5  104
PFU, as determined by the XC-plaque assay (25) (data not
shown). Additionally, viral genomic RNA was isolated from
the stocks and converted to cDNA, and viral RNA copy num-
bers were determined by qRT-PCR by using standard curves.
We determined that our standard infectious viral titer of 2.5 
104 PFU of LP-BM5 averaged approximately 1.3 million (0.2
million) copies of BM5eco RNA and 1.93 million (0.05 mil-
lion) copies of BM5def RNA. Similarly, the number of viral
genomes per 2.5  104 PFU for the BM5eco-rescued viral
preparations were as follows: (i) wt BM5def (transfection con-
trol), 1.14 million (0.14 million) copies of BM5eco RNA and
1.97 million (0.04 million) copies of BM5def RNA; (ii)
BM5defORF2aAUGmut, 1.12 million (0.2 million) copies of
BM5eco RNA and 1.82 million (0.04 million) copies of
BM5def RNA; (iii) BM5defORF2bAUGmut, 1.32 million (0.2
million) copies of BM5eco RNA and 1.9 million (0.03 mil-
lion) copies of BM5def RNA.
Ability of BM5def ORF2a and ORF2b AUGs to initiate
translation of GFP fusion proteins. In order to determine the
translational potential of the alternative ORF2a and ORF2b
AUGs, we first generated BM5defORF1AUGEGFP (as a pos-
itive control) and BM5defORF2aAUGEGFP and BM5def
ORF2bAUGEGFP tagged viruses. These constructs allow for
the expression of the ORF1 or ORF2a or ORF2b AUG-de-
fined reading frames as fusions to the N terminus of EGFP
(Fig. 2A). Thus, the EGFP gene, including its endogenous stop
codon, was cloned at the C terminus of, and in the same
reading frame as, either the ORF1, ORF2a, or ORF2b AUGs,
with no intervening in-frame stop codons. For the BM5def
ORF2aAUGEGFP construct, EGFP was cloned 5 of the
ORF2b initiation AUG to ensure that all EGFP expression
would necessarily emanate only from the ORF2a initiation
AUG. Stable transfectants of the EGFP-tagged BM5def vi-
ruses were generated in SC-1eco cells and analyzed for EGFP
fusion protein expression by fluorescence-activated cell sorting
(FACS). GFP expression was detected in cells carrying
BM5defORF1AUGEGFP as expected and also by BM5def
ORF2aAUGEGFP- or BM5defORF2bAUGEGFP-transfected
cells (Fig. 2A). Importantly, BM5defORF2a/2b AUG-directed
EGFP expression was detected at somewhat lower (24% lower
total mean fluorescence intensity) but still very substantial lev-
els compared to the conventional BM5def ORF1-directed lev-
els. Additionally, to ascertain how much EGFP expression in
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the BM5defORF2bAUGEGFP construct originated from the
ORF2b AUG specifically (and not as a read-through from the
upstream intact ORF2a AUG), we also generated a construct
wherein the ORF2a AUG was mutated and the EGFP gene
was cloned 5 of and in the same reading frame as the ORF2b
(BM5defORF2aAUGmut;ORF2bAUGEGFP, Fig. 2B). SC-1
eco
cells transfected with this BM5defORF2aAUGmut;
ORF2bAUGEGFP virus expressed considerable GFP (only
37% lower total mean fluorescence intensity than the
BM5defORF2bAUG carrying the unmutated ORF2a AUG),
confirming that the ORF2b initiation AUG was independently
capable of translating a fusion protein without any read-
through from the upstream intact ORF2a AUG (Fig. 2B).
To verify that the GFP was being translated from the initi-
ation AUGs of ORF2a or ORF2b and that the introduced
mutations were effective in disrupting ORF2a or ORF2b
AUG-initiated translation, EGFP was similarly engineered
into the BM5defORF2aAUGmut and BM5defORF2bAUGmut vi-
ruses (Fig. 2C). To generate the BM5defORF2aAUGmutEGFP
virus, EGFP was cloned 5 of the ORF2b initiation AUG.
Compared to the BM5defORF2aAUGEGFP, the total mean
fluorescence intensity of BM5defORF2aAUGmutEGFP was
consistently lowered in three independent experiments by
99%; essentially this mutant did not appear to express de-
tectable GFP (Fig. 2C). These data clearly show that the
ORF2a AUG is capable of initiating translation of a fusion
protein, and the introduced mutations inhibit ORF2a AUG-
initiated translation. In contrast, mutation of the ORF2b ini-
tiation codon did not completely inhibit the EGFP signal (Fig.
2C), as predicted from the results in Fig. 2B. Rather, the
mutated BM5defORF2bAUGmutEGFP expressed substantial
GFP (only 30% lower total mean fluorescence intensity than
BM5defORF2bAUG), most probably due to the read-through
from the intact ORF2a AUG (also see below).
BM5def ORF1-encoded gag is expressed in the
BM5defORF2aAUGmut or BM5defORF2bAUGmut mutants. To
confirm that the mutations introduced in BM5def ORF2a or
ORF2b AUGs are in no way detrimental to the translation of
FIG. 2. (A) BM5def gag ORF1AUG- versus ORF2AUG- directed EGFP expression. (B) BM5def ORF2bAUGEGFP versus
BM5defORF2aAUGmut;ORF2bAUGEGFP expression. (C) GFP expression in viruses carrying either the ORF2aAUGmut or ORF2bAUGmut muta-
tions. In all three panels, the dark gray filled-in histograms are the negative controls of untransfected Sc-1eco cells, while the light gray filled-in
histograms represent Sc-1eco cells transfected with BM5defORF1AUGEGFP. The black solid line and dashed line represent the following:
(A) Sc-1eco cells transfected with BM5defORF2aAUGEGFP or BM5defORF2bAUGEGFP viruses, respectively; (B) Sc-1
eco cells transfected with
BM5defORF2bAUGEGFP or BM5defORF2aAUGmut;ORF2bAUGEGFP viruses, respectively; (C) Sc-1
eco cells transfected with BM5def
ORF2aAUGmutEGFP or BM5defORF2bAUGmutEGFP viruses, respectively. These data are representative of three independent experiments. FACS
analyses for cells in panels A and C and in Fig. 3 were carried out on the same day while that for panel B was done independently. Each histogram
depicts a stable transfectant population which is representative of at least two independently transfected populations that were tested for GFP
expression by FACS.
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ORF1, which is required for viral pathogenesis, we also gen-
erated viruses with the ORF1AUGEGFP fusion construct in
both the BM5defORF2aAUGmut and BM5defORF2bAUGmut
viruses. The EGFP fragment was cloned in frame with the
initiating AUG, and at the C terminus, of ORF1 in both mu-
tants (Fig. 3). The wt BM5def carrying the ORF1AUGEGFP
fusion protein defined above was used as a positive control in
analogous FACS experiments. ORF1AUGEGFP expression
was detected in the BM5defORF2aAUGmut or BM5def
ORF2bAUGmut viruses at levels indistinguishable from this pos-
itive control (Fig. 3). These data confirm that ORF1 AUG-
initiated translation is not disrupted in the BM5def
ORF2aAUGmut or BM5defORF2bAUGmut mutants, thus allow-
ing us to address the potential need for ORF2 translation for
pathogenesis under conditions of normal levels of required
ORF1 product.
Activational and immunosuppressive parameters of MAIDS
pathogenesis are not induced by the BM5defORF2aAUGmut or
BM5defORF2bAUGmut mutants. To assess the pathogenicity of
BM5def viruses mutated to inhibit translation from their alter-
native ORF2 AUGs, B6 mice were infected with rescued prep-
arations carrying BM5eco virus and either the BM5def
ORF2aAUGmut or BM5defORF2bAUGmut mutant virus or with
positive (LP-BM5 and wt BM5def rescued with BM5eco) or
negative (phosphate-buffered saline) controls. Splenomegaly,
as a standard activational parameter characteristic of MAIDS
(10, 11), was determined 11 weeks postinfection (wpi) by
spleen weight (Fig. 4A). At 5, 9, and 11 wpi, serum IgG2a and
IgM levels were determined (11 wpi; Fig. 4B), as a measure of
the generalized hyper-Ig of MAIDS. Compared to the LP-
BM5 or wt BM5def rescued control-infected mice, B6 mice
infected with either the BM5defORF2aAUGmut (P  0.001) or
BM5defORF2bAUGmut (P  0.001) virus did not induce mea-
surable splenomegaly or hypergammaglobulinemia. This pat-
tern was replicated in three additional independent experi-
ments.
In addition, a standard panel of immunosuppressive param-
eters was measured at termination 11 wpi: responses to mito-
gens by T (ConA) versus B (lipopolysaccharide) cells, as well
as the generation of alloantigen-specific (anti-H-2d) CTL ac-
tivity. Again, in contrast to LP-BM5 or wt BM5def rescued
control-infected mice, B6 mice infected with the BM5eco-res-
cued BM5defORF2aAUGmut or BM5defORF2bAUGmut mu-
tants did not develop disease, i.e., they had normal mitogen
responses (Fig. 4C; data representative of four independent
experiments, P  0.001) and generation of CTL activity (Fig.
4D; data representative of three independent experiments).
These results were further confirmed by flow cytometric anal-
yses for the characteristic spleen cell phenotypic changes that
are observed in uninfected versus LP-BM5-infected B6 mice
(9, 14). LP-BM5 or wt BM5def rescued control-infected mice
showed the expected expanded populations of CD19 CD23
and CD4 Thy1.2 spleen cells, but these changes were not
observed in mice infected with the BM5defORF2aAUGmut or
BM5defORF2bAUGmut mutant (data not shown).
Determination of BM5def and BM5eco gag RNA levels in
infected mice. On termination of each experiment, we verified
the presence of the appropriate control and experimental vi-
ruses in infected mice and quantified their expression by qRT-
PCR assays for BM5eco and BM5def (7). Although there was
no evidence of MAIDS induction by the BM5def
ORF2aAUGmut or BM5defORF2bAUGmut preps, mice infected
with these mutants expressed substantial levels of both
BM5eco and BM5def (Fig. 5). BM5def gag RNA was more
abundant than BM5eco gag RNA in spleen cells from both
control and viral mutant-infected mice. These data are similar
to what our lab has observed previously (7) as well as to
BM5def and BM5eco gag RNA levels determined in the viral
stocks that were generated in vitro and used for infecting mice
FIG. 3. ORF1AUGEGFP expression in viruses carrying either the
ORF2aAUGmut or ORF2bAUGmut mutations. The dark gray filled-in
histogram is the negative controls of untransfected Sc-1eco cells while
the light gray filled-in histogram represents Sc-1eco cells transfected
with BM5defORF1AUGEGFP. The black solid line and dashed line
represent Sc-1eco cells transfected with BM5defORF1AUGEGFP
cloned into BM5defORF2aAUGmut or BM5defORF2bAUGmut viruses,
respectively. These data are representative of three independent ex-
periments.
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in this study (data not shown). BM5eco gag and BM5def gag
RNA levels from mice infected with the BM5def
ORF2aAUGmut or BM5defORF2bAUGmut mutant viruses were
only about two- to threefold lower than the viral loads for wt
rescued control and LP-BM5-infected mice (Fig. 5). It seems
very unlikely that this degree of difference in viral load would
be sufficient to account for the absence of disease induction
after infection by the mutated BM5def preparations. The
higher viral loads in the positive controls, in this case infection
with nonmutated viral preps, seem to simply reflect the fact
that in full-blown MAIDS the characteristic extensive lympho-
proliferation is a major contributor to the spread of the virus,
in addition to multiple rounds of infection by free virions. This
concept that B6 background mouse strains resistant to MAIDS
pathogenesis still exhibit a substantial viral load indicative of
normal initial infection and early viral spread has been further
supported by both viral titration experiments and the study of
several MAIDS-resistant versus -susceptible B6 strains, with
either of the genes knocked out (CD154, CD40, CD80/86) or
as chimeric CD40 transgenics (9, 10, 11). As we have previ-
ously discussed in some detail (9), these comparisons across
mouse strains have shown that distinctly measurable disease
can be observed under conditions that result in a few-fold
lower BM5def viral load at termination of the experiment. In
addition, on termination of each experiment, by using RT-PCR
we isolated the BM5def viruses from spleen cells and se-
quenced them. Sequencing data confirmed the presence of
only the wt BM5def in the mice infected with the positive
control viral preps, versus only the appropriate mutant se-
quence in the mice infected with the experimental viruses. An
FIG. 4. Susceptibility of BM5eco-rescued wt or mutant BM5def-infected B6 mice to MAIDS. (A) Spleen size (mg). (B) Serum IgM and IgG2a
response. (C) Spleen cell proliferation in response to T-cell mitogen (ConA, 2 g/ml) and B-cell mitogen (lipopolysaccharide, 10 g/ml).
(D) Allogeneic cytotoxic-T-lymphocyte responses of spleen cells at 11 wpi. E:T, effector-to-target ratio. Means and standard deviations represent
three mice per group and the data are representative of four independent experiments for panels A, B, and C and three independent experiments
for panel D. Statistical analyses were carried out on LP-BM5-infected mice and B6 mice infected with either BM5defORF2aAUGmut or
BM5defORF2bAUGmut (P  0.001 by Student t test). PBS, phosphate-buffered saline.
FIG. 5. Viral load for BM5eco gag and BM5def gag RNA quanti-
fied by qRT-PCR from spleen cells of infected mice at 11 wpi. These
qRT-PCR data are representative of RNA isolated from infected
spleens in four independent experiments.
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inherent advantage of this system is that any reversion of the
mutated to the wt sequence would have resulted in a defective
virus that would have caused disease. These data clearly sug-
gest that a virus different from what was initially injected into
the mice had not arisen to detectable levels as a result of
reversion during the 11-week course of infection.
In summary, based on (i) both activational and immunode-
ficiency parameters of MAIDS (Fig. 4), (ii) viral load data (Fig.
5), and (iii) sequence analysis of viruses isolated from mice 11
wpi, and ORF1/ORF2 expression data (Fig. 2 and 3), it is
evident that the viral mixes consisting of either wt BM5eco-
rescued ORF2aAUGmut or ORF2bAUGmut BM5def virus, each
with intact wt ORF1 expression capability, are essentially un-
able to induce disease. These data strongly suggest the exis-
tence of a novel ORF2 product(s) that is required for LP-BM5-
induced pathogenesis. The ORF2 product(s) may be initiated
from either the ORF2a or ORF2b AUG (Fig. 2), as disruption
of either one of their translational potentials leads to inhibition
of disease (Fig. 4). One interpretation of these findings is that
there is a requirement for both protein products of 193 and 30
aa, produced as separate entities from the ORF2a and ORF2b
AUGs, respectively. These proteins may be independently es-
sential in targeting different specific host cellular proteins. Al-
ternatively or in addition, the two alternative ORF2 transla-
tional products may function together to cause disease by
independently interacting with the same host cell protein tar-
get or combining to form a single ORF2a/ORF2b heterodimer.
As an option to two separate ORF2 protein products, it is
also possible that only a single protein initiating from the
ORF2a AUG is required. Thus, the data from the
BM5defORF2bAUGmutEGFP mutant virus (Fig. 2C) show
that, despite disrupting the initiation AUG of ORF2b, GFP is
still expressed (albeit at a reduced level) as a fusion protein,
apparently from the unaltered ORF2a AUG which is in the
same 1-nt reading frame as ORF2b (Fig. 2B). Importantly,
however, the BM5defORF2bAUGmut virus is unable to cause
disease. This finding could be explained based not on the
ORF2b AUG mutation as a block to translation initiation at
this site but rather on the basis of the introduction of a mis-
sense mutation at the ORF2b site in the ORF2a AUG-initi-
ated maximal ORF2 protein. Thus, the presence of threonine
instead of methionine may be deleterious to the structure of
the extended protein produced from the ORF2a AUG.
The results presented in this paper support the existence of
an alternative translation initiation mechanism in BM5def for
the expression of an ORF2-encoded gag product(s) and its
requirement in LP-BM5-induced pathogenesis. These data
have obvious implications for pursuing the molecular mecha-
nisms by which BM5def causes disease and studies are cur-
rently under way to identify the nature and function of the
necessary ORF2 product(s). Our data are interesting to com-
pare to the results of other labs that have also studied atypi-
cally encoded CTL epitopes, including in human immunode-
ficiency virus (2, 3, 6, 28). In particular, and comparable to our
novel BM5def ORF2a and/or ORF2b AUG(s)-encoded 193 or
30 aa protein(s), a previously unobserved, conserved 87-resi-
due protein encoded by influenza A virus has recently been
identified by first defining a CTL epitope encoded in an alter-
native translational ORF (6). This immunogenic influenza vi-
rus protein, PB1-F2, recognized by CD8 T cells, is derived
from a 1 alternative reading frame and may play a critical
role in pathogenesis by inducing apoptosis in host immune
cells that respond to influenza virus infection (6). Our identi-
fication of an immunodominant CTL epitope novelly ex-
pressed from an alternative translational gag ORF (20, 22),
combined with our present data that the ORF2-encoded ex-
tended gag product(s) have a functional role in disease induc-
tion, raise the possibility that alternative reading frame-derived
proteins may also be crucial in other disease models.
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